Nicole LaBrosse - Feb 2, 2022 Form 3 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, Chief Financial Officer
Signature
/s/ James R. Oehler as attorney-in-fact for Nicole LaBrosse
Stock symbol
HALO
Transactions as of
Feb 2, 2022
Transactions value $
$0
Form type
3
Date filed
2/11/2022, 03:21 PM
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HALO Common Stock 5.03K Feb 2, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HALO Option to Purchase Common Stock Feb 2, 2022 Common Stock 35K $22.50 Direct F1
holding HALO Option to Purchase Common Stock Feb 2, 2022 Common Stock 11.3K $12.07 Direct F1
holding HALO Option to Purchase Common Stock Feb 2, 2022 Common Stock 1.95K $12.49 Direct F1
holding HALO Option to Purchase Common Stock Feb 2, 2022 Common Stock 8.81K $18.41 Direct F1
holding HALO Option to Purchase Common Stock Feb 2, 2022 Common Stock 10.6K $16.65 Direct F1
holding HALO Option to Purchase Common Stock Feb 2, 2022 Common Stock 21.3K $19.98 Direct F1
holding HALO Option to Purchase Common Stock Feb 2, 2022 Common Stock 13K $49.84 Direct F1
holding HALO Restricted Stock Unit Feb 2, 2022 Common Stock 1.26K Direct F2
holding HALO Restricted Stock Unit Feb 2, 2022 Common Stock 2.78K Direct F2
holding HALO Restricted Stock Unit Feb 2, 2022 Common Stock 7.51K Direct F2
holding HALO Restricted Stock Unit Feb 2, 2022 Common Stock 5.02K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests one-fourth on such date and then 1/48th monthly thereafter.
F2 One-fourth of the original grant vests on such date and then one-fourth annually thereafter. Represents a restricted stock unit award with no exercise price.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney